These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND Ki-67 AND Treatment
133 results:

  • 1. Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.
    Wang Y; Xing H; Guo X; Chen W; Wang Y; Liang T; Wang H; Li Y; Jin S; Shi Y; Liu D; Yang T; Xia Y; Li J; Wu J; Liu Q; Qu T; Guo S; Li H; Zhang K; Wang Y; Ma W
    Cancer Med; 2024 Jul; 13(13):e7369. PubMed ID: 38970209
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
    Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
    Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of ki-67 expression levels in IDH-wildtype glioblastoma using logistic regression modelling of VASARI features.
    Bai L; Jiang J; Zhou J
    Neurosurg Rev; 2023 Dec; 47(1):20. PubMed ID: 38135816
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells.
    Patel KS; Yao J; Cho NS; Sanvito F; Tessema K; Alvarado A; Dudley L; Rodriguez F; Everson R; Cloughesy TF; Salamon N; Liau LM; Kornblum HI; Ellingson BM
    Neuro Oncol; 2024 Jan; 26(1):115-126. PubMed ID: 37591790
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.
    Jiang H; Zhu Q; Wang X; Li M; Shen S; Yang C; Zhao X; Li M; Ma G; Zhao X; Chen X; Yang J; Lin S
    Cancer Sci; 2023 Sep; 114(9):3708-3718. PubMed ID: 37332121
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Contribution of whole slide imaging-based deep learning in the assessment of intraoperative and postoperative sections in neuropathology.
    Shi L; Shen L; Jian J; Xia W; Yang KD; Tian Y; Huang J; Yuan B; Shen L; Liu Z; Zhang J; Zhang R; Wu K; Jing D; Gao X
    Brain Pathol; 2023 Jul; 33(4):e13160. PubMed ID: 37186490
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prediction of ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
    de Godoy LL; Chawla S; Brem S; Wang S; O'Rourke DM; Nasrallah MP; Desai A; Loevner LA; Liau LM; Mohan S
    J Neurooncol; 2023 May; 163(1):173-183. PubMed ID: 37129737
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
    Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An integrative non-invasive malignant brain tumors classification and ki-67 labeling index prediction pipeline with radiomics approach.
    Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
    Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion.
    Chen AT; Xiao Y; Tang X; Baqri M; Gao X; Reschke M; Sheu WC; Long G; Zhou Y; Deng G; Zhang S; Deng Y; Bai Z; Kim D; Huttner A; Kunes R; Günel M; Moliterno J; Saltzman WM; Fan R; Zhou J
    Neuro Oncol; 2023 Mar; 25(3):482-494. PubMed ID: 35901838
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Monocentric evaluation of ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
    Dumke R; Dumke C; Eberle F; Nimsky C; Keber U; Engenhart-Cabillic R; Lautenschläger S
    Strahlenther Onkol; 2022 Oct; 198(10):892-906. PubMed ID: 35612598
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Anaplastic pleomorphic xanthoastrocytoma - single-center analysis of 42 patients].
    Belyaev AY; Shugai SV; Kobyakov GL; Strunina YV; Batalov AI; Pronin IN; Usachev DY
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(2):45-54. PubMed ID: 35412712
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Glucose Influences the Response of
    Bielecka-Wajdman AM; Ludyga T; Smyk D; Smyk W; Mularska M; Świderek P; Majewski W; Mullins CS; Linnebacher M; Obuchowicz E
    Cancer Control; 2022; 29():10732748221075468. PubMed ID: 35225010
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Factors Independently Associated With Improved Progression-Free Survival After Surgical Resection in Patients With Spinal Cord astrocytomas: An Institutional Case Series.
    Helal A; Alvi MA; Everson M; Mikula AL; Cohen Cohen S; Bydon M; Krauss WE; Clarke MJ
    Oper Neurosurg (Hagerstown); 2022 Mar; 22(3):106-114. PubMed ID: 35030157
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
    Prosniak M; Kenyon LC; Hooper DC
    J Neuropathol Exp Neurol; 2021 Aug; 80(7):674-684. PubMed ID: 34297838
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of Immunohistochemical profiling of Glioblastoma multiforme on clinical outcomes: Real-world scenario in resource limited setting.
    Kumar N; Elangovan A; Madan R; Dracham C; Khosla D; Tripathi M; Gupta K; Kapoor R
    Clin Neurol Neurosurg; 2021 Aug; 207():106726. PubMed ID: 34116459
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 7.